The Oncology Institute Stock Market Value
| TOIIW Stock | USD 0.02 0 37.70% |
| Symbol | Oncology |
The Oncology Institute Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oncology Institute. If investors know Oncology will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oncology Institute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (602.09) | Revenue Per Share 4.873 | Quarterly Revenue Growth 0.229 | Return On Assets (0.19) | Return On Equity (1.26) |
The market value of The Oncology Institute is measured differently than its book value, which is the value of Oncology that is recorded on the company's balance sheet. Investors also form their own opinion of Oncology Institute's value that differs from its market value or its book value, called intrinsic value, which is Oncology Institute's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oncology Institute's market value can be influenced by many factors that don't directly affect Oncology Institute's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oncology Institute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncology Institute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncology Institute's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Oncology Institute 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oncology Institute's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oncology Institute.
| 12/15/2022 |
| 12/04/2024 |
If you would invest 0.00 in Oncology Institute on December 15, 2022 and sell it all today you would earn a total of 0.00 from holding The Oncology Institute or generate 0.0% return on investment in Oncology Institute over 720 days. Oncology Institute is related to or competes with Oncology Institute, and Talkspace. The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States More
Oncology Institute Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oncology Institute's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess The Oncology Institute upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 20.22 | |||
| Information Ratio | 0.0721 | |||
| Maximum Drawdown | 85.93 | |||
| Value At Risk | (27.03) | |||
| Potential Upside | 32.39 |
Oncology Institute Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oncology Institute's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oncology Institute's standard deviation. In reality, there are many statistical measures that can use Oncology Institute historical prices to predict the future Oncology Institute's volatility.| Risk Adjusted Performance | 0.0694 | |||
| Jensen Alpha | 1.84 | |||
| Total Risk Alpha | (1.03) | |||
| Sortino Ratio | 0.0639 | |||
| Treynor Ratio | (0.33) |
The Oncology Institute Backtested Returns
Oncology Institute is out of control given 3 months investment horizon. The Oncology Institute maintains Sharpe Ratio (i.e., Efficiency) of 0.1, which implies the firm had a 0.1% return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.78% are justified by taking the suggested risk. Use Oncology Institute Market Risk Adjusted Performance of (0.32), semi deviation of 15.62, and Coefficient Of Variation of 1275.33 to evaluate company specific risk that cannot be diversified away. Oncology Institute holds a performance score of 8 on a scale of zero to a hundred. The company holds a Beta of -4.28, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Oncology Institute are expected to decrease by larger amounts. On the other hand, during market turmoil, Oncology Institute is expected to outperform it. Use Oncology Institute sortino ratio, as well as the relationship between the semi variance and day median price , to analyze future returns on Oncology Institute.
Auto-correlation | 0.63 |
Good predictability
The Oncology Institute has good predictability. Overlapping area represents the amount of predictability between Oncology Institute time series from 15th of December 2022 to 10th of December 2023 and 10th of December 2023 to 4th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of The Oncology Institute price movement. The serial correlation of 0.63 indicates that roughly 63.0% of current Oncology Institute price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.63 | |
| Spearman Rank Test | 0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
The Oncology Institute lagged returns against current returns
Autocorrelation, which is Oncology Institute stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Oncology Institute's stock expected returns. We can calculate the autocorrelation of Oncology Institute returns to help us make a trade decision. For example, suppose you find that Oncology Institute has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Oncology Institute regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Oncology Institute stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Oncology Institute stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Oncology Institute stock over time.
Current vs Lagged Prices |
| Timeline |
Oncology Institute Lagged Returns
When evaluating Oncology Institute's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Oncology Institute stock have on its future price. Oncology Institute autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Oncology Institute autocorrelation shows the relationship between Oncology Institute stock current value and its past values and can show if there is a momentum factor associated with investing in The Oncology Institute.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Oncology Stock Analysis
When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.